Comparison · Metabolic health

GlucoTrust vs HepatoBurn: Skeptic's 2026 Comparison

Glucose-and-sleep pitch vs liver-and-fat pitch. Berberine vs gymnema sylvestre — both real ingredients, both undisclosed doses.

Updated Apr 20, 2026 Metabolic health 2 reviews · 1 verdict each

Side by side

Field GlucoTrust HepatoBurn
Verdict Skeptical Conditional
Rating (out of 10) 4.5 5.0
One-time price $69 $69
Best bundle price $49 per bottle $49 per bottle
Top cons (Skeptic Desk)
  • Chromium disclosed at 76 mcg — every positive glycemic trial uses 200–1,000 mcg/day; this dose is clinically inert
  • Gymnema dose is hidden inside the proprietary blend despite being the product's lead bioactive
  • All five active ingredients are hidden behind a proprietary blend — the berberine dose is the critical unknown
  • The liver-to-weight-loss causal chain is plausible but unproven at the finished-product level
Refund mechanism 60-day refund — universal checkout-processor enforced 60-day refund — universal checkout-processor enforced
Dose transparency Limited — key ingredient doses are hidden or hard to verify Limited — key ingredient doses are hidden or hard to verify
Skeptic Desk note GlucoTrust gets credit for including Gymnema sylvestre — an ingredient with genuine RCT evidence for post-prandial glucose control at 400 mg — and loses it immediately by hiding that dose inside a proprietary blend. Chromium is disclosed at 76 mcg, which is below every effective dose in the literature. Cinnamon's evidence is mixed enough to be ambiguous. The sleep claim exists solely to differentiate the product in a crowded glycemic-support category, not because the ingredients produce meaningful sedation. HepatoBurn occupies a rare position in this category: two of its five ingredients (berberine and silymarin) have genuine human RCT evidence at the right doses for the claimed mechanisms. The problem is that neither dose is disclosed. A proprietary blend concealing berberine is not a minor inconvenience — berberine's therapeutic window is dose-sensitive and meaningfully different at 500 mg versus 1,500 mg. Until those numbers appear on the label, this earns a Cautious rather than a Conditional.
Subscription / autoship One-time purchase listed One-time purchase listed
Full review Read the GlucoTrust review Read the HepatoBurn review

The skeptic's call

Neither GlucoTrust nor HepatoBurn clears the bar for an unconditional recommendation — both sit in the Skeptical-to-Conditional band that defines roughly nine out of ten ClickBank-channel supplements. Glucose-and-sleep pitch vs liver-and-fat pitch. Berberine vs gymnema sylvestre — both real ingredients, both undisclosed doses. Where they actually differ: GlucoTrust gets credit for including Gymnema sylvestre — an ingredient with genuine RCT evidence for post-prandial glucose control at 400 mg — and loses it immediately by hiding that dose inside a proprietary blend. By contrast, HepatoBurn reads as hepatoburn occupies a rare position in this category: two of its five ingredients (berberine and silymarin) have genuine human rct evidence at the right doses for the claimed mechanisms. GlucoTrust is the marginally less-bad pick if you are buyers specifically curious about gymnema sylvestre who want a single capsule convenience and accept that the dose is unverifiable or if you are pre-diabetic adults who have already addressed diet and exercise and want a supplementary glycemic support adjunct — not a replacement for medical management. HepatoBurn is the marginally less-bad pick if you are buyers specifically interested in berberine or silymarin who want a single-capsule convenience and are willing to accept dose opacity or if you are people with elevated liver enzymes who have discussed supplementation with a clinician and want an over-the-counter starting point. Skip both if you are on insulin or any sulfonylurea — gymnema has additive hypoglycemic effects and dose opacity makes co-management unsafe; you are buying primarily for sleep support — there is no credible sleep mechanism in this formula; you are taking metformin or any sulfonylurea — berberine has additive glycemic effects and undisclosed dosing makes co-management impossible. On the Skeptic Desk's own scoring, HepatoBurn is the less-bad option, separated from GlucoTrust by verdict tier (Skeptical vs Conditional). That is not a recommendation — it is a tiebreaker. If neither best-for profile fits you, the cheaper, more transparent commodity stack remains the better-evidence option than either bottle. Read the full reviews before clicking either checkout.

Buyer questions

Which is cheaper, GlucoTrust or HepatoBurn?
Both products list at roughly the same price tier (around $39–69 per bottle depending on bundle size). Verify final pricing on the seller checkout — bundle discounts, upsells, and shipping change the math more than the headline number.
Which has the better refund?
Identical, on paper. Both products are sold through the same third-party ClickBank-style checkout, which enforces a 60-day money-back guarantee on every product on the platform regardless of what the seller says. You file the refund with checkout support, not the seller. We have run real refund cycles on multiple products in this category in 2026 and the mechanism has held up. The harder issue is whether either product enrolls you in autoship or recurring billing — verify that on the order page before paying.
Are both real products, or is one a scam?
Both GlucoTrust and HepatoBurn are real products with real fulfillment and real refund mechanics. That is the legal definition of "not a scam." The harder question — whether the formula does what the sales page implies — is what each of our full reviews tries to answer. Neither product currently has a published clinical trial on the finished formula, which is the industry default in the ClickBank channel.
Should I just buy a commodity equivalent instead?
Often, yes. The Skeptic Desk's default recommendation across this category is the same: if you can identify the one or two ingredients in either GlucoTrust or HepatoBurn that actually have published evidence at studied doses, you can usually source those individually from a commodity brand at 20–40% of the monthly cost. The reason buyers still pick the bottle is format and convenience, not evidence. That is a defensible choice — just price it honestly against the alternative.
GlucoTrust vs HepatoBurn: which one would the Skeptic Desk pick?
Neither, if a clinically-dosed commodity stack is on the table. HepatoBurn is the less-bad of the two by verdict tier (Skeptical vs Conditional), but "less bad" is a tiebreaker for buyers who have already decided to buy a bottle in this category. Read both full reviews — linked above — before clicking any checkout.

More comparisons

Browse every metabolic health comparison →